Anjarium Biosciences Company
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
Technology:
Gene Therapy
Industry:
BioTech
Headquarters:
Schlieren
Founded Date:
2017
Employees Number:
1-10
Total Funding:
$60.4M
Register and Claim Ownership